share_log

Belgravia Hartford Capital Inc. Provides Corporate Update

Belgravia Hartford Capital Inc. Provides Corporate Update

贝尔格拉维亚哈特福德资本公司提供企业更新
newsfile ·  08/15 20:34

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce the appointment of Ms. Ava Tahmasebi as an independent director to the Board of the Company. Additionally, Dr. Shoaib Sheikh has been appointed as head of the company's advisory committee.

安大略省多伦多--(Newsfile Corp.,2024 年 8 月 15 日)-贝尔格拉维亚哈特福德资本公司(CSE: BLGV)(“Belgravia Hartford”、“Belgravia” 或 “公司”)欣然宣布任命艾娃·塔马塞比女士为公司董事会独立董事。此外,Shoaib Sheikh博士被任命为公司顾问委员会主席。

Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in driving innovation and business growth within the startup ecosystem. She holds a Doctor of Philosophy (Ph.D.) in Wireless Networks and has recently updated her skills through a Data Analytics program at the University of Toronto. Ms. Tahmasebi has played a pivotal role in mentoring over 50 startups, steering them towards notable success. As CEO of Startup Station, a Toronto-based startup studio with a focus on women entrepreneurs, she has refined her expertise in transforming nascent ideas into successful, market-ready businesses. Startup Station is a member of the National Angel Capital Organization (NACO).

Ava Tahmasebi女士是一位经验丰富的高管,在推动创业生态系统的创新和业务增长方面拥有十多年的经验。她拥有无线网络哲学博士(Ph.D.)学位,最近通过多伦多大学的数据分析课程更新了自己的技能。Tahmasebi女士在指导50多家初创公司,引导他们取得显著成功方面发挥了关键作用。作为Startup Station(一家总部位于多伦多、专注于女性企业家的创业工作室)的首席执行官,她在将新兴想法转化为成功的、可上市的企业方面不断完善自己的专业知识。创业站是全国天使资本组织(NACO)的成员。

Dr. Shoaib Sheikh, MD, FACS, is a surgeon who has served on multiple provincial, national and international boards and committees for the past 17 years. The nature of involvement has been from board of directors, executive committees, editorial boards and provincial review committees. Dr. Sheikh has served for two full terms on the Board of Governors of the American College of Surgeons which has 90,000 member surgeons and has served on the finance committee of the College of Surgeons. Dr. Shiekh also owns 8,414,095 common shares of Belgravia Hartford which represents 12.49% of the outstanding common shares of the Company.

FACS医学博士Shoaib Sheikh博士是一名外科医生,在过去的17年中曾在多个省、国家和国际董事会和委员会任职。参与的性质来自董事会、执行委员会、编辑委员会和省级审查委员会。谢赫博士曾在美国外科医生学会理事会任职两个完整任期,该学会拥有90,000名成员的外科医生,并曾在外科医生学院财务委员会任职。谢赫博士还拥有贝尔格莱维亚·哈特福德的8,414,095股普通股,占公司已发行普通股的12.49%。

Mr. Mehdi Azodi, The CEO & President of Belgravia stated "The addition of Ms. Tahmasebi to the board strengthens the governance and adds fresh perspective on future investments and due diligence process. The appointment of Dr. Sheikh provides the board and legal team with global business experience and access to capital injection for the company to build out a new business platform and fund the company's litigation affairs."

贝尔格莱维亚首席执行官兼总裁迈赫迪·阿佐迪表示:“Tahmasebi女士加入董事会加强了治理,为未来的投资和尽职调查流程增添了新的视角。谢赫博士的任命为董事会和法律团队提供了全球业务经验和资本注入的机会,使公司能够建立新的业务平台并为公司的诉讼事务提供资金。”

About Belgravia Hartford

关于贝尔格莱维亚·哈特福德

Belgravia Hartford Capital Inc. ("Belgravia" or the "Company") is a publicly traded investment holding company listed on the Canadian Securities Exchange. Belgravia is focused on growing its assets and holdings and increasing its net asset value (NAV). Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. It takes a multi-sector investment approach with emphasis in the resources and commodities sector. Belgravia and its investments are considered high risk holdings and it may expose shareholders to significant volatility and losses.

Belgravia Hartford Capital Inc.(“Belgravia” 或 “公司”)是一家在加拿大证券交易所上市的上市投资控股公司。Belgravia专注于增加其资产和持股量并增加其净资产价值(NAV)。Belgravia投资于位于法治司法管辖区的私营和上市公司的投资组合。它采取多部门投资方法,重点是资源和商品领域。Belgravia及其投资被视为高风险持股,可能使股东面临巨大的波动和损失。

For more information, please visit

欲了解更多信息,请访问

Forward-Looking Statements

前瞻性陈述

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, the timing for completion of research and development activities, the potential value of royalties, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by the Company, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

本新闻稿中列出的某些信息可能包含前瞻性陈述,这些陈述涉及大量已知和未知的风险和不确定性以及其他因素,这些因素可能导致公司的实际业绩、业绩或成就与此类前瞻性陈述所表达或暗示的任何未来业绩、业绩或成就存在重大差异。前瞻性陈述包括使用前瞻性术语的陈述,例如 “可能”、“将”、“期望”、“预期”、“相信”、“继续”、“潜在” 或否定或其中的其他变体或类似术语。此类前瞻性陈述包括但不限于有关计划投资活动和相关回报的陈述、研发活动的完成时间、特许权使用费的潜在价值以及其他非历史事实的陈述。这些前瞻性陈述存在许多风险和不确定性,其中某些风险和不确定性是公司无法控制的,包括但不限于市场趋势的变化、公司研究的完成、结果和时机、与资源资产相关的风险、总体经济状况的影响、大宗商品价格、行业状况、对监管、环境和政府批准的依赖以及获得额外融资的不确定性。请读者注意,编制此类信息时使用的假设虽然在准备时被认为是合理的,但可能不准确,因此,不应过度依赖前瞻性陈述。

For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca

欲了解更多信息,请联系:
总裁兼首席执行官迈赫迪·阿佐迪
贝尔格莱维亚哈特福德资本公司
(416) 779-3268
mazodi@blgv.ca

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发